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We present an automated microfluidic droplet generator/depositor for MALDI-TOF analysis allowing attomol 
detection of peptides from sub-nanomolar soltutions: a sensitivity which is a paramount importance for proteomics 
and diagnosis field. 
Droplet based microfluidic devices offer many advantages in integration of multiple biological or chemical 
processes, essential tools for biomarker/biological fluids analysis [1]. However the detection mainly relies on optical 
methods such as fluorescence which implies a labelling of target molecules but also suffers from a lack of 
sensitivity. At the opposite mass spectrometry is a highly sensitive technic based on a label free detection of analytes 
but interfacing droplet-based microfluidic and mass spectrometry is challenging and up to now there are few studies 
reported [2-3].  
We focus on the integration of a droplet based microfluidic system with a MALDI-TOF. We develop methods 
which prevent the use of surfactants: a crippling factor since surfactants led to high background noise, and then are 
not compatible with high sensitivity detection method. To circumvent this effect, we designed a chip which prevents 
droplets coalescence by spacing each droplet with a controlled volume of oil (Figure 1). This simple geometry 
allows to finely tune the amount of spotted droplets and controlled the coalescence. The microfluidic chip outlet is 
then connected to a capillary, and the droplets are transferred to a MALDI plate mounted on a motorized xy-stage. 
To estimate the potential of the platform, we developed a full optimized method (sample composition, matrix 
composition, droplet generation, deposition and analysis) of relevant proteomics biomarker: a native peptide 
Angiotensin II involved in several diseases [4-5]. First, we compared our system with a standard MALDI deposition 
procedure i.e. manual pipetting. The spectra of Figure 2 show 500nl of a solution of 10fmol/µl Angiotensin II -left 
pipette deposited and -right platform deposited. In both cases, the 1046.2 m/z peak of Angiotensin II is visible but 
in the former case the intensity is increased by one order of magnitude. A closer look to the deposits shows a 
concentration effect with the platform deposition (see insets figure 2). 
In a second step, we made a sensitivity test by depositing different concentrations of analytes. The Figure 3 shows 
the average peak intensity as a function of n the quantity deposited in femtomole. We record good intensity signal 
down to 100 attomoles (see inset figure 3). Below this threshold the spectra are very noisy (Figure 4-left).   
In order to increase the sensitivity of the method, we developed a multi-spotting deposit. By repeated deposition of 
droplets, we increase drastically the amount of peptides on the spot, and can then reach very low level of detection. 
As a proof the Figure 4 shows the spectra of sub-nM solution before (left) and after the multideposit (right). 
We developed a method which allows to generate single droplet in a microchip coupled with a MALDI-TOF 
analysis. We control the volume of sample deposit on each spot, and by multi-spotting we reached a very high 
sensitivity compatible with physiological concentration of proteomic biomarkers. 
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Figure 1. Principle of the droplet 
formation and MALDI deposition 
Figure 2. MALDI spectra. Left. Standard 
pipette deposit. Right. Microfluidic 
platform deposit. Inserts: Dried mixture 
of peptide/matrix before laser desorption. 
Figure 3. Average MS signal intensity as 
a function of the amount n (n from 22 
femtomoles to 17 attomoles) of 
Angiotensin II deposited on the MALDI 
plate by the microfluidic platform 
deposit.  
Figure 4. 
MALDI spectra of a 100 attomoles 
solution of Angiotensin II. Left. 
Microfluidic platform deposit. Right. 
Microfluidic platform multi-spotting 
deposit. Inserts: zoom on Angiotensin II 
peaks. 
